Ben Burnett
Stock Analyst at Stifel
(n/a)
# 4,350
Out of 4,711 analysts
4
Total ratings
n/a
Success rate
-46.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ben Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JSPR Jasper Therapeutics | Initiates: Buy | $86 | $21.57 | +298.70% | 1 | Jun 27, 2024 | |
| CABA Cabaletta Bio | Maintains: Buy | $32 | $2.38 | +1,244.54% | 2 | Jun 17, 2024 | |
| CRSP CRISPR Therapeutics AG | Initiates: Hold | $52 | $40.72 | +27.70% | 1 | Mar 5, 2020 |
Jasper Therapeutics
Jun 27, 2024
Initiates: Buy
Price Target: $86
Current: $21.57
Upside: +298.70%
Cabaletta Bio
Jun 17, 2024
Maintains: Buy
Price Target: $32
Current: $2.38
Upside: +1,244.54%
CRISPR Therapeutics AG
Mar 5, 2020
Initiates: Hold
Price Target: $52
Current: $40.72
Upside: +27.70%